Skip to main content
. Author manuscript; available in PMC: 2025 Sep 3.
Published in final edited form as: Trends Biotechnol. 2024 Feb 2;42(7):929–937. doi: 10.1016/j.tibtech.2024.01.002

Figure 1.

Figure 1

(Key Figure): Microbial delivery roadmap. By following the roadmap developed for the controlled delivery of small-molecule therapeutics, including formulation for maintaining efficacy (through maintaining viability for microbes), selection of the proper materials for controlled release, and evaluation of the release, similar advantages to small-molecule delivery are expected for bacteria.